88 related articles for article (PubMed ID: 15501248)
1. The permeability-reducing effects of prostacyclin and inhibition of Rho kinase do not counteract endotoxin-induced increase in permeability in cat skeletal muscle.
Lundblad C; Bentzer P; Grände PO
Microvasc Res; 2004 Nov; 68(3):286-94. PubMed ID: 15501248
[TBL] [Abstract][Full Text] [Related]
2. Endothelin-1 reduces microvascular fluid permeability through secondary release of prostacyclin in cat Skeletal muscle.
Bentzer P; Holbeck S; Grände PO
Microvasc Res; 2002 Jan; 63(1):50-60. PubMed ID: 11749072
[TBL] [Abstract][Full Text] [Related]
3. Endotoxin increases both protein and fluid microvascular permeability in cat skeletal muscle.
Holbeck S; Grände PO
Crit Care Med; 2003 Feb; 31(2):560-5. PubMed ID: 12576966
[TBL] [Abstract][Full Text] [Related]
4. Inhibition of Rho kinase decreases hydraulic and protein microvascular permeability in cat skeletal muscle.
Lundblad C; Bentzer P; Grände PO
Microvasc Res; 2003 Sep; 66(2):126-33. PubMed ID: 12935770
[TBL] [Abstract][Full Text] [Related]
5. Nitric oxide and prostacyclin play a role in the regulation of microvascular protein and hydraulic permeability in cat skeletal muscle.
Persson J; Ekelund U; Grände PO
Microcirculation; 2003 Apr; 10(2):233-43. PubMed ID: 12700590
[TBL] [Abstract][Full Text] [Related]
6. Low-dose prostacyclin restores an increased protein permeability after trauma in cat skeletal muscle.
Bentzer P; Grände PO
J Trauma; 2004 Feb; 56(2):385-92. PubMed ID: 14960984
[TBL] [Abstract][Full Text] [Related]
7. The role of Rho-associated kinase in differential regulation by statins of interleukin-1beta- and lipopolysaccharide-mediated nuclear factor kappaB activation and inducible nitric-oxide synthase gene expression in vascular smooth muscle cells.
Wei CY; Huang KC; Chou YH; Hsieh PF; Lin KH; Lin WW
Mol Pharmacol; 2006 Mar; 69(3):960-7. PubMed ID: 16317111
[TBL] [Abstract][Full Text] [Related]
8. Inhibition of Rho-kinase normalizes nonspecific hyperresponsiveness in passively sensitized airway smooth muscle preparations.
Schaafsma D; Zuidhof AB; Nelemans SA; Zaagsma J; Meurs H
Eur J Pharmacol; 2006 Feb; 531(1-3):145-50. PubMed ID: 16451800
[TBL] [Abstract][Full Text] [Related]
9. Tocolytic effect of a Rho-kinase inhibitor in a mouse model of lipopolysaccharide-induced preterm delivery.
Tahara M; Kawagishi R; Sawada K; Morishige K; Sakata M; Tasaka K; Murata Y
Am J Obstet Gynecol; 2005 Mar; 192(3):903-8. PubMed ID: 15746689
[TBL] [Abstract][Full Text] [Related]
10. Rho-kinase inhibition suppresses bladder hyperactivity in spontaneously hypertensive rats.
Rajasekaran M; Wilkes N; Kuntz S; E Albo M
Neurourol Urodyn; 2005; 24(3):295-300. PubMed ID: 15791631
[TBL] [Abstract][Full Text] [Related]
11. Effects of Y-27632, a selective Rho-kinase inhibitor, on myocardial preconditioning in anesthetized rats.
Demiryürek S; Kara AF; Celik A; Tarakçioğlu M; Bağci C; Demiryürek AT
Biochem Pharmacol; 2005 Jan; 69(1):49-58. PubMed ID: 15588713
[TBL] [Abstract][Full Text] [Related]
12. Inhalation of the Rho-kinase inhibitor Y-27632 reverses allergen-induced airway hyperresponsiveness after the early and late asthmatic reaction.
Schaafsma D; Bos IS; Zuidhof AB; Zaagsma J; Meurs H
Respir Res; 2006 Sep; 7(1):121. PubMed ID: 17002806
[TBL] [Abstract][Full Text] [Related]
13. Impaired cAMP and Rac 1 signaling contribute to TNF-alpha-induced endothelial barrier breakdown in microvascular endothelium.
Schlegel N; Waschke J
Microcirculation; 2009 Aug; 16(6):521-33. PubMed ID: 19504398
[TBL] [Abstract][Full Text] [Related]
14. Attenuation of endotoxin-induced acute lung injury by the Rho-associated kinase inhibitor, Y-27632.
Tasaka S; Koh H; Yamada W; Shimizu M; Ogawa Y; Hasegawa N; Yamaguchi K; Ishii Y; Richer SE; Doerschuk CM; Ishizaka A
Am J Respir Cell Mol Biol; 2005 Jun; 32(6):504-10. PubMed ID: 15778497
[TBL] [Abstract][Full Text] [Related]
15. Inhibition of RhoA/Rho-kinase pathway suppresses the expression of type I collagen induced by TGF-beta2 in human retinal pigment epithelial cells.
Itoh Y; Kimoto K; Imaizumi M; Nakatsuka K
Exp Eye Res; 2007 Mar; 84(3):464-72. PubMed ID: 17217948
[TBL] [Abstract][Full Text] [Related]
16. Proerectile effects of the Rho-kinase inhibitor (S)-(+)-2-methyl-1-[(4-methyl-5-isoquinolinyl)sulfonyl]homopiperazine (H-1152) in the rat penis.
Teixeira CE; Ying Z; Webb RC
J Pharmacol Exp Ther; 2005 Oct; 315(1):155-62. PubMed ID: 15976017
[TBL] [Abstract][Full Text] [Related]
17. Role of prostacyclin and nitric oxide in regulation of basal microvascular hydraulic permeability in cat skeletal muscle.
Möller AD; Grände PO
J Vasc Res; 1999; 36(3):245-52. PubMed ID: 10393511
[TBL] [Abstract][Full Text] [Related]
18. Role of Rho-kinase in guinea-pig gallbladder smooth muscle contraction.
Quinn T; Feighery R; Baird AW
Eur J Pharmacol; 2006 Mar; 534(1-3):210-7. PubMed ID: 16499905
[TBL] [Abstract][Full Text] [Related]
19. Preventive effect of Y-27632, a selective Rho-kinase inhibitor, on ischemia/reperfusion-induced acute renal failure in rats.
Teraishi K; Kurata H; Nakajima A; Takaoka M; Matsumura Y
Eur J Pharmacol; 2004 Nov; 505(1-3):205-11. PubMed ID: 15556154
[TBL] [Abstract][Full Text] [Related]
20. Differential Rho-kinase dependency of full and partial muscarinic receptor agonists in airway smooth muscle contraction.
Schaafsma D; Boterman M; de Jong AM; Hovens I; Penninks JM; Nelemans SA; Meurs H; Zaagsma J
Br J Pharmacol; 2006 Apr; 147(7):737-43. PubMed ID: 16432505
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
